|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| C07K 16/28 | (2006.01) | ||
| C07D 491/22 | (2006.01) | ||
| C07D 317/44 | (2006.01) | ||
| C07D 317/70 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 4217398 |
| (13) | Kind of document | T |
| (96) | European patent application number | 22796992.0 |
| Date of filing the European patent application | 2022-04-29 | |
| (97) | Date of publication of the European application | 2023-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2025-09-24 |
| (46) | Date of publication of the claims translation | 2025-11-25 |
| (86) | Number | PCT/US2022/072008 |
| Date | 2022-04-29 |
| (87) | Number | WO 2022/232834 |
| Date | 2022-11-03 |
| (30) | Number | Date | Country code |
| 202163181963 P | 2021-04-29 | US |
| (72) |
PHILLIPS, Andrew C. , US
REILLY, Regina M. , US
DOHERTY, George A. , US
JI, Cheng , US
BRUNCKO, Milan , US
BOGHAERT, Erwin R. , US
ANDERSON, Mark , US
|
| (73) |
AbbVie Manufacturing Management Unlimited Company ,
70 Sir John Rogerson's Quay, Dublin, D02 R296,
IE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Anti-C-MET antikūno ir vaisto konjugatai |
| ANTI-C-MET ANTIBODY DRUG CONJUGATES |
| Payment date | Validity (years) | Amount | |
| 2026-03-23 | 5 | 115.00 EUR |
| 2027-04-29 |